Overview
Düsseldorf, June 17, 2025 – McDermott Will & Emery advised Great Point Partners (“GPP”), a Greenwich-based private investment firm focused on the health care industry, on the acquisition of a majority stake in Eutecma, a German-based developer of packaging solutions for pharmaceutical cold chain shipments.
With this partnership, Eutecma has also acquired Resolvision, Eutecma’s proprietary re-use machine technology utilized at its Refreshment Centers.
Founded in 2008, Eutecma is a leading designer and manufacturer of sustainable, modular, and reusable temperature-controlled packaging solutions for the pharmaceutical industry. The company is headquartered in Mannheim, Germany, with Refreshment Centers in the EU and the US.
Great Point Partners, founded in 2003 and based in Greenwich, CT, is a leading health care investment firm with 30 professionals, investing in the United States, Canada, and Western Europe.
The McDermott team advising GPP was led by partner Jan Hückel, and comprised partners Thomas Ammermann, Robert Clagg, Nathan Barnett, Eleanor West, Jana Grieb, Heiko Kermer, Carina Kant, Daniel Zucker, Brian Mead, Nick Paul, Jeffrey Holdvogt, Barrick Bollman, Jeff Cassidy, counsel Marcus Fischer, Laura Stammwitz, Bettina Holzberger, Raymond Paretzky, as well as associates Darius Mosleh, Malte Arndt, Marisa Montoya, Katharina Hoffmeister, Carina Schützeberg, Lennart Neumann and Anja Bertrand.
About McDermott
Leading organizations turn to global law firm McDermott Will & Emery for a better way to address legal challenges, connect with those at the forefront, and drive stronger outcomes. Working across more than 20 offices globally, our 1,400+ lawyers act on data-driven insights, deep relationships, and unmatched industry experience to deliver on our commitment of Always Better.
